Goodbye To Screws And Plates, Scientists Developed 3-Minute ‘Bone Glue’ That Repairs Broken Bones Naturally

Chinese scientists have unveiled a groundbreaking bio-adhesive, popularly known as “Bone-02,” that can bond fractured bones within just three minutes. This innovation was inspired by the adhesive properties of oysters, which can attach firmly to wet surfaces, a concept now translated into medical science.

Unlike traditional implants such as metal plates or screws, the new bone glue is completely bioabsorbable. As the bone naturally heals, the adhesive is gradually absorbed by the body, effectively eliminating the need for secondary surgery to remove any hardware.

Reports from early clinical trials indicate that the glue provides an impressive bonding strength exceeding 400 pounds (around 180 kg) and achieves stable fixation even in wet, blood-rich surgical environments. This could revolutionize the way fractures are treated in orthopedic surgery.

What Is “Bone-02”?

The newly developed Bone-02 is a bio-inspired, wet-setting bone adhesive created by a team of researchers in China. It has been designed to set and harden within 2–3 minutes when injected directly between bone fragments. The material was developed using chemical principles inspired by marine organisms, especially oysters, whose adhesive proteins function effectively underwater.

 

View this post on Instagram

 

A post shared by Adarsh Gupta (@adarshh.gupta)

Surgeons apply the glue through a small incision using a syringe or applicator. Once injected, the glue spreads evenly, fills gaps between bone fragments, and hardens rapidly to provide firm stabilization. It is particularly useful in fracture sites where traditional screws or plates are difficult to apply, such as small bones in the wrist, ankle, or spine.

Why It Matters in Orthopedic Care

Bone fractures often require invasive surgery involving metal plates, screws, or rods. While these devices provide stability, they also carry risks such as infection, tissue damage, and the need for another surgery to remove them later.

A bioabsorbable adhesive offers a potential alternative by reducing surgical time, minimizing post-surgery complications, and allowing natural healing without foreign metal implants. For elderly patients or children, who may require hardware removal in future years, this could significantly improve recovery outcomes and comfort.

Reported Performance: Key Highlights

Feature	Reported Data	Description
Setting Time	2–3 minutes	Achieves strong adhesion even in moist, bleeding surgical sites
Bonding Strength	>400 lbs (≈180 kg)	Provides firm stabilization for bone fragments
Shear Strength	~0.5 MPa	Indicates high resistance to movement and load
Absorbability	Fully bioabsorbable	Naturally degrades as bone heals, avoiding removal surgery
Early Clinical Use	150+ cases reported	Tested in several hospitals across Zhejiang Province

These results highlight that the adhesive could reduce operating time while ensuring immediate fracture stabilization, marking a major leap forward in orthopedic repair technology.

Early Clinical Experience

Initial testing has taken place at Sir Run Run Shaw Hospital in Zhejiang, under orthopedic specialist Dr. Lin Xianfeng. One widely cited case involved a wrist fracture repair performed through a small 3 cm incision, where the glue successfully restored stability within minutes. The patient’s bone showed normal healing within three months, without complications.

Over 150 clinical applications have been reported across multiple hospitals in China, primarily for minor fractures and joint injuries. However, these trials remain in their early stages, and detailed peer-reviewed results are awaited to confirm safety and long-term performance.

Safety and Biocompatibility

A major advantage of Bone-02 lies in its biocompatibility. The glue’s ingredients reportedly break down into harmless compounds as the bone regenerates, ensuring that no toxic residues remain in the body. Researchers claim that this biodegradation process aligns with the body’s natural healing timeline, helping new bone tissue to replace the adhesive structure seamlessly.

While the preliminary data are encouraging, comprehensive studies covering tissue responses, degradation byproducts, and potential allergic reactions are yet to be published. Such research will be crucial to confirming its safety profile before global approval.

Limitations and Pending Data

Despite the excitement surrounding Bone-02, there are still critical questions that remain unanswered:

• Peer-reviewed data on the adhesive’s composition, chemical reactions, and long-term stability are not yet available.
• Regulatory approval status within or outside China has not been publicly confirmed.
• Comparative clinical trials against metal fixation methods have yet to be conducted.

Until these studies are released, the claims remain promising but preliminary. International validation will be needed before the product can enter widespread medical use.

Potential Impact in Medicine

If the adhesive passes international safety and efficacy evaluations, it could bring transformative changes in multiple medical fields:

• Trauma Surgery: Rapid fixation of small, complex fractures or osteoporotic bone fragments.
• Pediatric Orthopedics: Safer repairs without metal implants that need future removal.
• Minimally Invasive Surgery: Shorter operation times, smaller incisions, and faster recovery.

Such applications could drastically improve patient outcomes, reduce hospital stays, and lower the burden on healthcare systems.

Globally, researchers have long sought a bone adhesive capable of working under wet conditions. The Bone-02 innovation fits within this ongoing scientific pursuit of combining mechanical strength with biological compatibility. Similar studies in Europe and North America are exploring calcium-phosphate and polymer-based glues, but most struggle to match the performance required in human surgery.

China’s reported success, if verified, could place it at the forefront of medical biomaterial development and inspire international collaborations in orthopedic bioengineering.

Key Takeaways

• The Bone-02 bone glue can reportedly repair fractures in about three minutes and provide high bonding strength.
• It is bioabsorbable, eliminating the need for a second surgery to remove implants.
• Early clinical trials show promising results, but global peer-reviewed confirmation and regulatory approval are pending.
• If validated, it could become a game-changer in orthopedic medicine, especially for minimally invasive and pediatric surgeries.